BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36766822)

  • 1. The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.
    Lindenmann J; Fediuk M; Fink-Neuboeck N; Mykoliuk I; Taucher E; Pichler M; Smolle J; Smolle-Juettner FM
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].
    Qiang G; Yu Q; Liang C; Song Z; Shi B; Guo Y; Liu D
    Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):215-220. PubMed ID: 29587946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of obstructive lung disease on survival of never smokers with resected non-small-cell lung cancer: a comparison with smokers.
    Akamine T; Tagawa T; Shimokawa M; Matsubara T; Kozuma Y; Haratake N; Takamori S; Toyokawa G; Maehara Y
    Interact Cardiovasc Thorac Surg; 2019 May; 28(5):735-743. PubMed ID: 30602039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC.
    Sekine Y; Behnia M; Fujisawa T
    Lung Cancer; 2002 Jul; 37(1):95-101. PubMed ID: 12057873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Chronic Obstructive Pulmonary Disease on the Long-term Prognosis of Patients Undergoing Lobectomy for Non-small-cell Lung Cancer: A Propensity Score-matched Analysis.
    Matsudo K; Takenaka T; Hashinokuchi A; Nagano T; Kinoshita F; Takamori S; Akamine T; Kohno M; Miura N; Yoshizumi T
    Anticancer Res; 2023 Nov; 43(11):5215-5222. PubMed ID: 37909968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
    Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease in stage I non-small cell lung cancer that underwent anatomic resection: the role of a recurrence promoter.
    Kuo CH; Wu CY; Lee KY; Lin SM; Chung FT; Lo YL; Liu CY; Hsiung TC; Yang CT; Wu YC
    COPD; 2014 Aug; 11(4):407-13. PubMed ID: 24475998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
    Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.
    Dong W; Zhu Y; Du Y; Wang L; Feng X; Ma S
    Clin Respir J; 2020 Apr; 14(4):345-352. PubMed ID: 31876095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD).
    Wei S; Chen F; Liu R; Fu D; Wang Y; Zhang B; Ren D; Ren F; Song Z; Chen J; Xu S
    Thorac Cancer; 2020 Jul; 11(7):1784-1789. PubMed ID: 32374491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
    Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
    BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Video-assisted thoracoscopic lobectomy in non-small-cell lung cancer patients with chronic obstructive pulmonary disease is associated with lower pulmonary complications than open lobectomy: a propensity score-matched analysis.
    Jeon JH; Kang CH; Kim HS; Seong YW; Park IK; Kim YT; Kim JH
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):640-5. PubMed ID: 24052605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of chronic obstructive pulmonary disease on surgical outcome.
    Senbaklavaci O
    Int Surg; 2014; 99(4):319-24. PubMed ID: 25058759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival significance of coexisting chronic obstructive pulmonary disease in patients with early lung cancer after curative surgery.
    Saji H; Miyazawa T; Sakai H; Kimura Y; Tsuda M; Wakiyama Y; Marushima H; Kojima K; Nakamura H
    Thorac Cancer; 2018 Jan; 9(1):19-24. PubMed ID: 28976075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection.
    Sekine Y; Yamada Y; Chiyo M; Iwata T; Nakajima T; Yasufuku K; Suzuki M; Fujisawa T
    Ann Thorac Surg; 2007 Sep; 84(3):946-50. PubMed ID: 17720404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary disease.
    Yamanashi K; Marumo S; Shoji T; Fukui T; Sumitomo R; Otake Y; Sakuramoto M; Fukui M; Huang CL
    Gen Thorac Cardiovasc Surg; 2015 Dec; 63(12):652-9. PubMed ID: 26419246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
    Ajimizu H; Ozasa H; Sato S; Funazo T; Sakamori Y; Nomizo T; Kuninaga K; Ogimoto T; Hosoya K; Yamazoe M; Tsuji T; Yoshida H; Itotani R; Ueno K; Kim YH; Muro S; Hirai T
    Sci Rep; 2021 Dec; 11(1):23677. PubMed ID: 34880386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.